Division of Infectious Diseases

Coleman Rotstein

M.D., FRCPC, FACP, FIDSA

Clinical Professor, Department of Medicine

Director, Division of Infectious Diseases

Chief, Infectious Disease Service, Hamilton Health Sciences

Chair, Clinical Trials Committee of the Canadian Infectious Disease Society

Elected Fellow, Infectious Diseases Society of America and the American College of Physicians

Education and Professional Standing

Dr. Rotstein received a Bachelor of Science at the University of Toronto and earned his MD degree from the University of Calgary. He completed his specialty training in Internal Medicine at the University of Toronto and pursued further subspecialty training in Infectious Diseases & Immunology at the Medical University of South Carolina in Charleston.

Dr. Rotstein is Former President of the Canadian Infectious Disease Society, Past-President of the Association of Medical Microbiology and Infectious Diseases Canada, Chair of the Clinical Trials Committee of the Canadian Infectious Disease Society, and Elected Fellow of the Infectious Diseases Society of America and the American College of Physicians. He is a reviewer for several international journals and Associate Editor of the Canadian Journal of Infectious Diseases. Dr. Rotstein has a long history of interest and involvement in postgraduate medical education, and was the longest-standing director of the Infectious Diseases Residency Training Program at McMaster University.

Research Interests

Dr. Rotstein's research has focussed mainly on antibacterial agents, infections in the immunocompromised host, and fungal infections in cancer patients.

Selected Publications

  1. Salama S, Rotstein C, Mandell L. Using electronic software (theratracz) to monitor linezolid use in a tertiary care hospital. 11th International Congress on Infectious Diseases in Cancun, Mexico, March 4-7, 2004.
  2. Salama S, Rotstein C. Controlling nephrotoxicity with Abelcet: Experience in a tertiary care hospital, as compared to other North American Centres. Presentation at the Canadian Population Therapeutics Forum 2000 in Montreal, Quebec, May 1-2, 2000.
  3. Rotstein C, Amsterdam D, Mandell L, Yamamura D. Comparative in vitro activities of trovafloxacin, levofloxacin, sparfloxacin, ciprofloxacin and other antimicrobial agents against bloodstream isolates of gram-positive cocci. Presentation at the 66th Conjoint Meeting on Infectious Diseases in Toronto, Ontario, November 9-12, l998.
  4. Laverdiere M, Rotstein C, Bow EJ, Carr D, Moghaddam N, Ioannou S and the Canadian Fluconazole Study Group. The impact of fluconazole prophylaxis on fungal colonization and subsequent infection in cancer neutropenic patients. Presentation at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Ontario, September 28 to October 1, l997. Abstract LM-85.
  5. Rotstein C, Bow E, Laverdiere M, Carr D, Moghaddam N, Ioannou S. A multicentre, randomized, placebo-controlled trial of fluconazole prophylaxis for fungal infection in neutropenic cancer patients. Presentation at the l996 annual meeting of the American Society of Hematology. Orange County, Florida, December, l996